Nobutoshi Morozumi

A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations

Hisao Imai, Kyoichi Kaira, Kensuke Suzuki et al. · Lung Cancer · 2018 · 53 citations

Medicine, Oncology, Pharmacology +15

Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study

Kazuhiro Asami, Tomonobu Koizumi, Kazuya Hirai et al. · Clinical Lung Cancer · 2011 · 49 citations

Medicine, Oncology, Pharmacology +11

Clinical outcomes in elderly patients administered gefitinib as first-line treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer: retrospective analysis in a Nagano Lung Cancer Research Group Study

Kazunari Tateishi, Takashi Ichiyama, Kazuya Hirai et al. · Medical Oncology · 2013 · 33 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

Hisao Imai, Satoshi Wasamoto, Ou Yamaguchi et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 30 citations · Full text

Medicine, Oncology, Pharmacology +9